NSE - Delayed Quote INR
Quick Heal Technologies Limited (QUICKHEAL.NS)
294.60
-4.90
(-1.64%)
At close: 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
2,795,300
2,795,300
2,917,500
2,780,900
3,419,000
Cost of Revenue
1,926,800
1,926,800
1,758,600
1,642,400
1,498,300
Gross Profit
868,500
868,500
1,158,900
1,138,500
1,920,700
Operating Expense
1,064,000
1,064,000
1,109,400
1,272,500
1,023,700
Operating Income
-195,500
-195,500
49,500
-134,000
897,000
Net Non Operating Interest Income Expense
-2,200
-2,200
-1,300
17,800
29,000
Pretax Income
10,000
10,000
262,100
80,200
1,086,800
Tax Provision
-40,400
-40,400
19,700
16,200
254,900
Net Income Common Stockholders
50,400
50,400
242,400
64,000
831,900
Diluted NI Available to Com Stockholders
50,400
50,400
242,400
64,000
831,900
Basic EPS
0.94
0.94
4.56
1.14
14.01
Diluted EPS
0.94
0.94
4.48
1.14
13.94
Basic Average Shares
53,617.02
53,617.02
53,157.90
55,928.13
59,381.64
Diluted Average Shares
53,617.02
53,617.02
54,107.14
56,089.53
59,696.15
Rent Expense Supplemental
--
--
14,900
13,800
14,900
Total Expenses
2,990,800
2,990,800
2,868,000
2,914,900
2,522,000
Net Income from Continuing & Discontinued Operation
50,400
50,400
242,400
64,000
831,900
Normalized Income
50,400
50,400
242,400
-47,960.10
742,724.12
Interest Income
--
--
12,900
17,800
29,000
Interest Expense
2,200
2,200
1,300
0
--
Net Interest Income
-2,200
-2,200
-1,300
17,800
29,000
EBIT
12,200
12,200
263,400
80,200
897,000
EBITDA
141,800
141,800
389,400
240,100
1,070,800
Reconciled Cost of Revenue
1,926,800
1,926,800
1,758,600
1,642,400
1,498,300
Reconciled Depreciation
129,600
129,600
126,000
159,900
173,800
Net Income from Continuing Operation Net Minority Interest
50,400
50,400
242,400
64,000
831,900
Total Unusual Items Excluding Goodwill
--
--
139,900
140,300
116,500
Total Unusual Items
--
--
139,900
140,300
116,500
Normalized EBITDA
141,800
141,800
389,400
99,800
954,300
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
28,339.90
27,324.12
3/31/2022 - 2/18/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade